Corporate ActionMay 31, 2026, 08:01 PM
BriaCell Prices $4.7M Common Share Offering
AI Summary
BriaCell Therapeutics Corp. announced the pricing of a best-efforts offering of 1,449,300 common shares at $3.25 per share. The offering is expected to generate approximately $4.7 million in gross proceeds and is anticipated to close on June 2, 2026. The company intends to use the net proceeds for working capital requirements, general corporate purposes, and the advancement of business objectives.
Key Highlights
- BriaCell priced a best-efforts offering of 1,449,300 common shares.
- Each common share is being sold at an offering price of $3.25.
- Gross proceeds from the offering are expected to be approximately $4.7 million.
- The offering is anticipated to close on June 2, 2026.
- Net proceeds will be used for working capital, general corporate purposes, and business objectives.
- ThinkEquity is acting as the sole placement agent for the offering.
Price Impact
More from BCTX